The recent deal between diagnostics giant Abbott Laboratories and the small Canadian company BioCurex sent a wave of excitement through industry observers and investors. The reaction stemmed from the realisation of the enormousness of the deal for BioCurex in terms of the potential future prospects that the partnership brings.